Indoco Remedies share price has plunged 4% and is presently trading at Rs 210.9.
Meanwhile, the BSE HEALTHCARE index is at 41,182.2 (down 0.2%).
Among the top losers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (down 1.7%) and KIMS (down 1.3%).
NARAYANA HRUDAYALAYA (up 2.6%) and Pfizer (up 1.3%) are among the top gainers today.
Over the last one year, Indoco Remedies has moved down from Rs 288.4 to Rs 210.9, registering a loss of Rs 77.6 (down 26.9%).
On the other hand, the BSE HEALTHCARE index has moved down from 43,143.6 to 41,182.2, registering a loss of 4.5% during the last 12 months.
The top losers among the BSE HEALTHCARE index stocks during this same period were COHANCE LIFESCIENCES (down 64.0%), SYNGENE INTERNATIONAL (down 43.0%) and Natco Pharma (down 37.5%).
Live Now: The Small Cap Proxy Players Briefing
The BSE Sensex is at 82,250.6 (up 0.5%).
The top gainers among the BSE Sensex today are Axis Bank (up 2.1%) and Eternal Ltd (up 1.4%). The most traded stocks in the BSE Sensex are Bajaj Finserv and Eternal Ltd.
In the meantime, NSE Nifty is at 25,252.1 (up 0.3%). ONGC and Coal India are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 76,520.4 to 82,250.6, registering a gain of 5,730.2 points (up 7.5%).
Indoco Remedies net profit grew 8.0% YoY to Rs -92 million for the quarter ended September 2025, compared to a loss of Rs 100 million a year ago. Net sales rose 12.0% to Rs 4,847 million during the period as against Rs 4,327 million in July-September 2024.
For the year ended March 2025, Indoco Remedies reported 180.4% decrease in net profit to Rs -780 million compared to net profit of Rs 970 million during FY24. Revenue of the company fell 8.4% to Rs 16,649 million during FY25.
The current Price to earnings ratio of Indoco Remedies, based on rolling 12 month earnings, stands at -16.9.
Image source: Chunumunu/www.istockphoto.com
Equitymaster requests your view! Post a comment on "Indoco Remedies Plunges 4%; BSE HEALTHCARE Index Down 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!